Office of Biotechnology Activities    National Institutes of Health - Office of Science Policy   RAC December 4, 2002 - Presentation Materials Day 1 Bethesda, Maryland An Adverse Event in a Gene Transfer Clinical Trial for X-Linked Severe Combined Immunodeficiency Disease (SCID)     Theodore Friedmann, M.D., RAC Chair     Slides     Review of FDA Biological Response Modifiers Advisory Committee Meeting     Stephanie L. Simek, Ph.D., U.S. Food and Drug Administration     Slides     Review of October 29, 2002, RAC Planning Session     Stephen Rose, Ph.D., and/or Theodore Friedmann, M.D.     Slides     Adverse Events in Clinical Trials Using Retroviral Vectors     Alexander Rakowsky, M.D., Office of Biotechnology Activities, NIH     Slides     Monitoring Research Participants in Clinical Trials Using Retroviral Vectors     Theodore Friedmann, M.D., and Diane Wara, M.D., Moderator     Slides     Monitoring for Insertional Oncogenesis and Clonality of Hemotopoiesis after Gene Therapy     Slides     ADJOURN     Top of Page

6705 Rockledge Drive, Suite 750, MSC 7985 Bethesda, MD 20892-7985 (For all non-USPS mail, please use ZIP code 20817) Phone: 301-496-9838, Fax: 301-496-9839 E-mail OBA at oba@od.nih.gov

RDNA326